Leukemia News

The National Academy of Medicine announced the election of 90 regular members and 10 international members.

Adults undergoing chimeric antigen receptor T-cell therapy are at low risk for major adverse cardiovascular events, according to data published in JACC: CardioOncology.

Female adolescent and young adult cancer survivors reported higher rates of perceived infertility risk and frequently overestimated or underestimated their risk, according to study results published in JAMA Network Open.

A young girl growing up in revolutionary-era Iran had a clear but lofty goal — cure cancer.

Revumenib conferred complete remission or complete remission with partial hematologic recovery in nearly one-quarter of patients with two acute leukemia subtypes, according to the agent’s manufacturer.

ASCO released a research statement outlining new recommendations regarding the appropriate assessment of ovarian toxicity in cancer clinical trials.

Nearly seven in 10 premature cancer-related deaths among women could have been avoided through primary prevention, early detection or suitable access to cancer care, according to a report.

The FDA expanded the approval of bosutinib to include treatment of certain children with chronic myelogenous leukemia.

The FDA announced several regulatory actions.

Jorge Cortes, MD, received Society of Hematologic Oncology’s Michael J. Keating Outstanding Achievement Award.